Townsquare Capital LLC Novo Nordisk A S Transaction History

Townsquare Capital LLC

$7.19 Billion
Q2 2024

A detailed history of Townsquare Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Townsquare Capital LLC holds 389,980 shares of NVO stock, worth $46.4 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

389,980

Previous 343,656 13.48%

Holding current value

$46.4 Million

Previous $44.1 Million 26.15%

% of portfolio

0.77%

Previous 0.66%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $5.68 Million - $6.81 Million	46,324 Added 13.48%	389,980 $55.7 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $148,672 - $197,899	1,456 Added 0.43%	343,656 $44.1 Million
Q4 2023 Feb 15, 2024	SELL	$87.78 - $105.45 $1.54 Million - $1.85 Million	-17,552 Reduced 4.88%	342,200 $35.4 Million
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $21.4 Million - $46.9 Million	235,277 Added 189.02%	359,752 $32.7 Million
Q2 2023 Nov 13, 2023	BUY	$155.98 - $172.65 $3.01 Million - $3.33 Million	19,305 Added 18.36%	124,475 $20.1 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $2.14 Million - $2.57 Million	-16,170 Reduced 13.33%	105,170 $16.7 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $261,502 - $345,091	2,550 Added 2.15%	121,340 $16.4 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $286,697 - $351,842	3,009 Added 2.6%	118,790 $11.8 Million
Q2 2022 Aug 08, 2022	BUY	$103.24 - $121.81 $240,033 - $283,208	2,325 Added 2.05%	115,781 $12.9 Million
Q1 2022 Apr 28, 2022	BUY	$93.1 - $112.54 $889,384 - $1.08 Million	9,553 Added 9.19%	113,456 $12.6 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $1.2 Million - $1.47 Million	12,523 Added 13.7%	103,903 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $103,245 - $130,396	1,223 Added 1.36%	91,380 $8.77 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $953,938 - $1.2 Million	14,099 Added 18.54%	90,157 $7.67 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $33,194 - $37,530	495 Added 0.66%	76,058 $5.13 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $502,367 - $580,289	7,863 Added 11.61%	75,563 $5.28 Million
Q3 2020 Dec 01, 2020	BUY	$63.69 - $70.22 $646,453 - $712,733	10,150 Added 17.64%	67,700 $4.68 Million
Q2 2020 Aug 17, 2020	BUY	$58.54 - $67.94 $40,743 - $47,286	696 Added 1.22%	57,550 $3.75 Million
Q1 2020 May 18, 2020	BUY	$49.46 - $64.78 $703,617 - $921,560	14,226 Added 33.37%	56,854 $3.61 Million
Q4 2019 May 18, 2020	BUY	$49.86 - $58.26 $365,772 - $427,395	7,336 Added 20.79%	42,628 $2.47 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $368,435 - $414,082	7,750 Added 28.14%	35,292 $1.99 Million
Q2 2019 Aug 15, 2019	SELL	$46.79 - $52.47 $2.66 Million - $2.98 Million	-56,842 Reduced 67.36%	27,542 $1.34 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $1.72 Million - $1.95 Million	37,141 Added 78.62%	84,384 $4.41 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $1.96 Million - $2.23 Million	47,243 New	47,243 $2.31 Million

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $269B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.

Account

Townsquare Capital LLC Novo Nordisk A S Transaction History